Clinical Trials Browser

INDUSTRY × Leukemia, B-Cell × Antigens, CD19 × Clear all

NCT04648475 2023-04-18

Safety and Efficacy of CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT04649983 2023-04-18

CD19 and CD22 Targeted CAR-T Cell Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell